Neurocrine Biosciences Inc (NAS:NBIX)
$ 142 3.52 (2.54%) Market Cap: 14.29 Bil Enterprise Value: 13.59 Bil PE Ratio: 39.12 PB Ratio: 5.99 GF Score: 89/100

Neurocrine Biosciences Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2020 / 03:00PM GMT
Release Date Price: $123.37 (-0.02%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Great. I want to welcome everyone to the Jefferies Healthcare Conference today. I want to introduce our next company. We have Neurocrine Biosciences, and their CEO, Kevin Gorman.

This is going to be a fireside chat. So welcome, Kevin. Thanks for taking time out. I know you're in the midst of going to the beach and sitting on the beach in San Diego. So thanks for taking 25 minutes to speak with investors.

Questions & Answers

Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

But let's get to it. You had a really good Q1. You weathered I think -- or weathering COVID at the time. If you could just talk maybe about where the situation is as it relates to any COVID impact that you've been seeing over the last few months with INGREZZA.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Yes. Thank you, Biren, and Jefferies for the opportunity to speak here today. I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot